City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 19 Written by Matthew Zola Press Release Matthew Zola Next Next City Therapeutics Announces Pricing of Upsized Initial Public Offering
City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 19 Written by Matthew Zola Press Release Matthew Zola
